Orphan designation: Idronoxil Treatment of soft tissue sarcoma, 22/05/2023 Positive
Orphan designation: Idronoxil Treatment of soft tissue sarcoma, 22/05/2023 Positive
Orphan designation: Idronoxil Treatment of soft tissue sarcoma, 22/05/2023 Positive
Orphan designation: Humanised IgG4 monoclonal antibody against active complement component 1, subcomponent s Treatment of chronic inflammatory demyelinating polyneuropathy, 22/05/2023 Positive
Orphan designation: Adeno-associated virus serotype 9 expressing a transcription factor for the SCN1A gene Treatment of Dravet syndrome, 22/05/2023 Positive
PSUSA nationally authorised products template
Innovation in medicines
Major update of the SME user guide
Support to SMEs
Annex - National provisions for SMEs applicable to the pharmaceutical sector
User guide for micro, small and medium-sized enterprises
Guideline on the clinical evaluation of anticancer medicinal products - Revision 6